GPI 3000Alternative Names: NPC 17742
Latest Information Update: 02 Jul 2001
At a glance
- Originator Scios
- Class Amino acids; Antiepileptic drugs; Neuroprotectants; Small molecules
- Mechanism of Action Glutamate receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Epilepsy; Neurological disorders